Task: Answer the multiple-choice question.
Query: Which drug exhibits a -15.226\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCCn1ccnc1
b COc1ccc(CCNC(=O)Cn2nnc(C(=O)Nc3cccc(C)c3C)c2N)cc1OC
c CC(=O)Cc1nsc(NC(=O)c2ccc(-c3ccc(F)cc3)o2)n1
d NS(=O)(=O)c1ccc(NC(=O)CSc2ncn[nH]2)cc1
Answer: a. CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCCn1ccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCCn1ccnc1
CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCCn1ccnc1
2-(2,4-dichlorophenoxy)-N-(3-imidazol-1-ylpropyl)propanamide